drugset
drugset / Trial / NCT03670160

Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome

NCT03670160 ↗

Phase 2 Completed 25 enrolled University of Tennessee Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare clonidine versus phenobarbital as adjunctive therapy in those infants who have failed monotherapy with morphine sulfate for neonatal abstinence syndrome (NAS).

Timeline

Start
2018-10-01
Primary completion
2020-05-31
Completion
2020-05-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clonidine Other / unclassified 5 ug/kg —
Comparator Phenobarbital Unknown 5 mg/kg —

Indications

neonatal abstinence syndrome